Open Access

[Corrigendum] Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation

  • Authors:
    • Long Wang
    • Wei-Guang Lu
    • Jun Shi
    • Hong-Yang Zhang
    • Xiao-Long Xu
    • Bo Gao
    • Qiang Huang
    • Xiao-Jie Li
    • Ya-Qian Hu
    • Qiang Jie
    • Zhuo-Jing Luo
    • Liu Yang
  • View Affiliations

  • Published online on: July 31, 2023     https://doi.org/10.3892/mmr.2023.13061
  • Article Number: 174
  • Copyright : © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

September-2023
Volume 28 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang L, Lu W, Shi J, Zhang H, Xu X, Gao B, Huang Q, Li X, Hu Y, Jie Q, Jie Q, et al: [Corrigendum] Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation. Mol Med Rep 28: 174, 2023
APA
Wang, L., Lu, W., Shi, J., Zhang, H., Xu, X., Gao, B. ... Yang, L. (2023). [Corrigendum] Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation. Molecular Medicine Reports, 28, 174. https://doi.org/10.3892/mmr.2023.13061
MLA
Wang, L., Lu, W., Shi, J., Zhang, H., Xu, X., Gao, B., Huang, Q., Li, X., Hu, Y., Jie, Q., Luo, Z., Yang, L."[Corrigendum] Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation". Molecular Medicine Reports 28.3 (2023): 174.
Chicago
Wang, L., Lu, W., Shi, J., Zhang, H., Xu, X., Gao, B., Huang, Q., Li, X., Hu, Y., Jie, Q., Luo, Z., Yang, L."[Corrigendum] Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation". Molecular Medicine Reports 28, no. 3 (2023): 174. https://doi.org/10.3892/mmr.2023.13061